APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Glipizide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Glipizide Market Outlook and Growth Opportunities 2026

Report ID 173995340422 December 2025191 pages

Choose your research edition.

Industry ResearchGlipizide Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Glipizide Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Glipizide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glipizide Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Glipizide Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Glipizide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Glipizide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glipizide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glipizide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Glipizide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Glipizide market include CCPC, TEVA, Lukang Pharma, United Laboratories, Jumpcan, Pfizer, PIDI, Disha Pharma and Jingfeng Zhiyao, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glipizide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glipizide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glipizide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glipizide market size, projected growth trends, production technologies, key applications, and end-use industries.

Glipizide Segment by Company

CCPC

TEVA

Lukang Pharma

United Laboratories

Jumpcan

Pfizer

PIDI

Disha Pharma

Jingfeng Zhiyao

Yashica Pharma

Apotex

Glipizide Segment by Type

Glipizide Tablets

Glipizide Sustained Release Tablets

Others

Glipizide Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Glipizide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Glipizide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glipizide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glipizide significant trends, drivers, influence factors in global and regions.

6. To analyze Glipizide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glipizide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glipizide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glipizide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glipizide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glipizide industry.

Chapter 3: Detailed analysis of Glipizide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glipizide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glipizide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glipizide Industry Trends Table 2. Glipizide Industry Drivers Table 3. Glipizide Industry Opportunities and Challenges Table 4. Glipizide Industry Restraints Table 5. Global Glipizide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glipizide Revenue Share by Company (2021-2026) Table 7. Global Glipizide Sales Volume by Company (kg) & (2021-2026) Table 8. Global Glipizide Sales Volume Share by Company (2021-2026) Table 9. Global Glipizide Average Price (US$/kg) of Company (2021-2026) Table 10. Global Glipizide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glipizide Key Company Manufacturing Base & Headquarters Table 12. Global Glipizide Company, Product Type & Application Table 13. Global Glipizide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glipizide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Glipizide Tablets Table 18. Significant Companies of Glipizide Sustained Release Tablets Table 19. Significant Companies of Others Table 20. Global Glipizide Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 21. Global Glipizide Sales Volume by Type (2021-2026) & (kg) Table 22. Global Glipizide Sales Volume by Type (2027-2032) & (kg) Table 23. Global Glipizide Sales Volume Share by Type (2021-2026) Table 24. Global Glipizide Sales Volume Share by Type (2027-2032) Table 25. Global Glipizide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Glipizide Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Glipizide Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Glipizide Sales Value Share by Type (2021-2026) Table 29. Global Glipizide Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Pharmacies Table 31. Significant Companies of Online Pharmacies Table 32. Significant Companies of Retail Pharmacies Table 33. Global Glipizide Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 34. Global Glipizide Sales Volume by Application (2021-2026) & (kg) Table 35. Global Glipizide Sales Volume by Application (2027-2032) & (kg) Table 36. Global Glipizide Sales Volume Share by Application (2021-2026) Table 37. Global Glipizide Sales Volume Share by Application (2027-2032) Table 38. Global Glipizide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Glipizide Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Glipizide Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Glipizide Sales Value Share by Application (2021-2026) Table 42. Global Glipizide Sales Value Share by Application (2027-2032) Table 43. Global Glipizide Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 44. Global Glipizide Sales by Region (2021-2026) & (kg) Table 45. Global Glipizide Sales Market Share by Region (2021-2026) Table 46. Global Glipizide Sales by Region (2027-2032) & (kg) Table 47. Global Glipizide Sales Market Share by Region (2027-2032) Table 48. Global Glipizide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Glipizide Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Glipizide Sales Value Share by Region (2021-2026) Table 51. Global Glipizide Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Glipizide Sales Value Share by Region (2027-2032) Table 53. Global Glipizide Market Average Price (US$/kg) by Region (2021-2026) Table 54. Global Glipizide Market Average Price (US$/kg) by Region (2027-2032) Table 55. Global Glipizide Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 56. Global Glipizide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Glipizide Sales by Country (2021-2026) & (kg) Table 58. Global Glipizide Sales Market Share by Country (2021-2026) Table 59. Global Glipizide Sales by Country (2027-2032) & (kg) Table 60. Global Glipizide Sales Market Share by Country (2027-2032) Table 61. Global Glipizide Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Glipizide Sales Value Market Share by Country (2021-2026) Table 63. Global Glipizide Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Glipizide Sales Value Market Share by Country (2027-2032) Table 65. CCPC Company Information Table 66. CCPC Business Overview Table 67. CCPC Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 68. CCPC Glipizide Product Portfolio Table 69. CCPC Recent Development Table 70. TEVA Company Information Table 71. TEVA Business Overview Table 72. TEVA Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 73. TEVA Glipizide Product Portfolio Table 74. TEVA Recent Development Table 75. Lukang Pharma Company Information Table 76. Lukang Pharma Business Overview Table 77. Lukang Pharma Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 78. Lukang Pharma Glipizide Product Portfolio Table 79. Lukang Pharma Recent Development Table 80. United Laboratories Company Information Table 81. United Laboratories Business Overview Table 82. United Laboratories Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 83. United Laboratories Glipizide Product Portfolio Table 84. United Laboratories Recent Development Table 85. Jumpcan Company Information Table 86. Jumpcan Business Overview Table 87. Jumpcan Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 88. Jumpcan Glipizide Product Portfolio Table 89. Jumpcan Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 93. Pfizer Glipizide Product Portfolio Table 94. Pfizer Recent Development Table 95. PIDI Company Information Table 96. PIDI Business Overview Table 97. PIDI Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 98. PIDI Glipizide Product Portfolio Table 99. PIDI Recent Development Table 100. Disha Pharma Company Information Table 101. Disha Pharma Business Overview Table 102. Disha Pharma Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 103. Disha Pharma Glipizide Product Portfolio Table 104. Disha Pharma Recent Development Table 105. Jingfeng Zhiyao Company Information Table 106. Jingfeng Zhiyao Business Overview Table 107. Jingfeng Zhiyao Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 108. Jingfeng Zhiyao Glipizide Product Portfolio Table 109. Jingfeng Zhiyao Recent Development Table 110. Yashica Pharma Company Information Table 111. Yashica Pharma Business Overview Table 112. Yashica Pharma Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 113. Yashica Pharma Glipizide Product Portfolio Table 114. Yashica Pharma Recent Development Table 115. Apotex Company Information Table 116. Apotex Business Overview Table 117. Apotex Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 118. Apotex Glipizide Product Portfolio Table 119. Apotex Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Glipizide Distributors List Table 123. Glipizide Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Glipizide Product Image Figure 2. Global Glipizide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glipizide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glipizide Sales (2021-2032) & (kg) Figure 5. Global Glipizide Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Glipizide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Glipizide Tablets Image Figure 10. Glipizide Sustained Release Tablets Image Figure 11. Others Image Figure 12. Global Glipizide Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 13. Global Glipizide Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Glipizide Sales Volume Share by Type (2021-2032) Figure 15. Global Glipizide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Glipizide Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Glipizide Sales Value Share by Type (2021-2032) Figure 18. Hospital Pharmacies Image Figure 19. Online Pharmacies Image Figure 20. Retail Pharmacies Image Figure 21. Global Glipizide Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 22. Global Glipizide Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Glipizide Sales Volume Share by Application (2021-2032) Figure 24. Global Glipizide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Glipizide Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Glipizide Sales Value Share by Application (2021-2032) Figure 27. Global Glipizide Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 28. Global Glipizide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Glipizide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Glipizide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Glipizide Sales Value (2021-2032) & (US$ Million) Figure 32. North America Glipizide Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Glipizide Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Glipizide Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Glipizide Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Glipizide Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Glipizide Sales Value (2021-2032) & (US$ Million) Figure 38. South America Glipizide Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Glipizide Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Glipizide Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Glipizide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Glipizide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Glipizide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Glipizide Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Glipizide Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Glipizide Tablets
  • Glipizide Sustained Release Tablets
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • CCPC
  • TEVA
  • Lukang Pharma
  • United Laboratories
  • Jumpcan
  • Pfizer
  • PIDI
  • Disha Pharma
  • Jingfeng Zhiyao
  • Yashica Pharma
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glipizide Sales Value (2021-2032)
  4. 1.2.2 Global Glipizide Sales Volume (2021-2032)
  5. 1.2.3 Global Glipizide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glipizide Market Dynamics
  1. 2.1 Glipizide Industry Trends
  2. 2.2 Glipizide Industry Drivers
  3. 2.3 Glipizide Industry Opportunities and Challenges
  4. 2.4 Glipizide Industry Restraints
3 Glipizide Market by Company
  1. 3.1 Global Glipizide Company Revenue Ranking in 2025
  2. 3.2 Global Glipizide Revenue by Company (2021-2026)
  3. 3.3 Global Glipizide Sales Volume by Company (2021-2026)
  4. 3.4 Global Glipizide Average Price by Company (2021-2026)
  5. 3.5 Global Glipizide Company Ranking (2024-2026)
  6. 3.6 Global Glipizide Company Manufacturing Base and Headquarters
  7. 3.7 Global Glipizide Company Product Type and Application
  8. 3.8 Global Glipizide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glipizide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glipizide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glipizide Market by Type
  1. 4.1 Glipizide Type Introduction
  2. 4.1.1 Glipizide Tablets
  3. 4.1.2 Glipizide Sustained Release Tablets
  4. 4.1.3 Others
  5. 4.2 Global Glipizide Sales Volume by Type
  6. 4.2.1 Global Glipizide Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Glipizide Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Glipizide Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Glipizide Sales Value by Type
  10. 4.3.1 Global Glipizide Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Glipizide Sales Value by Type (2021-2032)
  12. 4.3.3 Global Glipizide Sales Value Share by Type (2021-2032)
5 Glipizide Market by Application
  1. 5.1 Glipizide Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Glipizide Sales Volume by Application
  6. 5.2.1 Global Glipizide Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Glipizide Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Glipizide Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Glipizide Sales Value by Application
  10. 5.3.1 Global Glipizide Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Glipizide Sales Value by Application (2021-2032)
  12. 5.3.3 Global Glipizide Sales Value Share by Application (2021-2032)
6 Glipizide Regional Sales and Value Analysis
  1. 6.1 Global Glipizide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glipizide Sales by Region (2021-2032)
  3. 6.2.1 Global Glipizide Sales by Region: 2021-2026
  4. 6.2.2 Global Glipizide Sales by Region (2027-2032)
  5. 6.3 Global Glipizide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glipizide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glipizide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glipizide Sales Value by Region (2027-2032)
  9. 6.5 Global Glipizide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glipizide Sales Value (2021-2032)
  12. 6.6.2 North America Glipizide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glipizide Sales Value (2021-2032)
  15. 6.7.2 Europe Glipizide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glipizide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glipizide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glipizide Sales Value (2021-2032)
  21. 6.9.2 South America Glipizide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glipizide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glipizide Sales Value Share by Country, 2025 VS 2032
7 Glipizide Country-level Sales and Value Analysis
  1. 7.1 Global Glipizide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glipizide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glipizide Sales by Country (2021-2032)
  4. 7.3.1 Global Glipizide Sales by Country (2021-2026)
  5. 7.3.2 Global Glipizide Sales by Country (2027-2032)
  6. 7.4 Global Glipizide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glipizide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glipizide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glipizide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glipizide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glipizide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glipizide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glipizide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glipizide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glipizide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glipizide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glipizide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glipizide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glipizide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glipizide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glipizide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glipizide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glipizide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glipizide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glipizide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glipizide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glipizide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glipizide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glipizide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glipizide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glipizide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glipizide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glipizide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glipizide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glipizide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glipizide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glipizide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glipizide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glipizide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glipizide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glipizide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glipizide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glipizide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glipizide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glipizide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glipizide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glipizide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glipizide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glipizide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glipizide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glipizide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glipizide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glipizide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glipizide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glipizide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glipizide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glipizide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glipizide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glipizide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glipizide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glipizide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glipizide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glipizide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glipizide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glipizide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glipizide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glipizide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glipizide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glipizide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glipizide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glipizide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glipizide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glipizide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glipizide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glipizide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glipizide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glipizide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glipizide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glipizide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glipizide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glipizide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glipizide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glipizide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glipizide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glipizide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glipizide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glipizide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glipizide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glipizide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glipizide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glipizide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glipizide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CCPC
  2. 8.1.1 CCPC Company Information
  3. 8.1.2 CCPC Business Overview
  4. 8.1.3 CCPC Glipizide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CCPC Glipizide Product Portfolio
  6. 8.1.5 CCPC Recent Developments
  7. 8.2 TEVA
  8. 8.2.1 TEVA Company Information
  9. 8.2.2 TEVA Business Overview
  10. 8.2.3 TEVA Glipizide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 TEVA Glipizide Product Portfolio
  12. 8.2.5 TEVA Recent Developments
  13. 8.3 Lukang Pharma
  14. 8.3.1 Lukang Pharma Company Information
  15. 8.3.2 Lukang Pharma Business Overview
  16. 8.3.3 Lukang Pharma Glipizide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lukang Pharma Glipizide Product Portfolio
  18. 8.3.5 Lukang Pharma Recent Developments
  19. 8.4 United Laboratories
  20. 8.4.1 United Laboratories Company Information
  21. 8.4.2 United Laboratories Business Overview
  22. 8.4.3 United Laboratories Glipizide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 United Laboratories Glipizide Product Portfolio
  24. 8.4.5 United Laboratories Recent Developments
  25. 8.5 Jumpcan
  26. 8.5.1 Jumpcan Company Information
  27. 8.5.2 Jumpcan Business Overview
  28. 8.5.3 Jumpcan Glipizide Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jumpcan Glipizide Product Portfolio
  30. 8.5.5 Jumpcan Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Glipizide Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Glipizide Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 PIDI
  38. 8.7.1 PIDI Company Information
  39. 8.7.2 PIDI Business Overview
  40. 8.7.3 PIDI Glipizide Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 PIDI Glipizide Product Portfolio
  42. 8.7.5 PIDI Recent Developments
  43. 8.8 Disha Pharma
  44. 8.8.1 Disha Pharma Company Information
  45. 8.8.2 Disha Pharma Business Overview
  46. 8.8.3 Disha Pharma Glipizide Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Disha Pharma Glipizide Product Portfolio
  48. 8.8.5 Disha Pharma Recent Developments
  49. 8.9 Jingfeng Zhiyao
  50. 8.9.1 Jingfeng Zhiyao Company Information
  51. 8.9.2 Jingfeng Zhiyao Business Overview
  52. 8.9.3 Jingfeng Zhiyao Glipizide Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jingfeng Zhiyao Glipizide Product Portfolio
  54. 8.9.5 Jingfeng Zhiyao Recent Developments
  55. 8.10 Yashica Pharma
  56. 8.10.1 Yashica Pharma Company Information
  57. 8.10.2 Yashica Pharma Business Overview
  58. 8.10.3 Yashica Pharma Glipizide Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Yashica Pharma Glipizide Product Portfolio
  60. 8.10.5 Yashica Pharma Recent Developments
  61. 8.11 Apotex
  62. 8.11.1 Apotex Company Information
  63. 8.11.2 Apotex Business Overview
  64. 8.11.3 Apotex Glipizide Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Apotex Glipizide Product Portfolio
  66. 8.11.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glipizide Value Chain Analysis
  2. 9.1.1 Glipizide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glipizide Sales Mode & Process
  6. 9.2 Glipizide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glipizide Distributors
  9. 9.2.3 Glipizide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst